Recall
FDAHealthDecember 11, 2025

Instrumentation Laboratory — The product is used for the evaluation of the intrinsic coagulation pathway, APTT substitution test and the monitoring of heparin therapy.

⚠️ Potential for microbial contamination.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 11, 2025

Worldwide - US Nationwide distribution in the states of CA, FL, IL, MN, MS, NE, OH, TX, WI and the countries of Belgium, Netherlands, Luxembourg, Switzerland, China, Hong Kong, Israel, Italy, South Korea, Lithuania, Macao, Malaysia, Philippines, Qatar, Romania, Turkey, Kosovo.

What's affected?

Product
The product is used for the evaluation of the intrinsic coagulation pathway, APTT substitution test and the monitoring of heparin therapy.
Lot code
N1136730

Additional details

Part Number: 0020006800. UDI-DI: 08426950078920. Lot Number: N1136730. Expiration Date 12/31/2025.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 7,720 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.